Falling Influence: Influenza fighters have limited effects | Science News

SUPPORT SCIENCE NEWS

Science News is a nonprofit.

Help us keep you informed.


News

Falling Influence: Influenza fighters have limited effects

By
10:41am, September 28, 2005

The most readily available drugs against influenza have abruptly declined in effectiveness in the past decade, and flu vaccines offer elderly people only modest protection against illness, according to two new analyses.

The findings lay bare limitations of both countermeasures, sounding a discouraging note as flu season draws near in the Northern Hemisphere.

One study finds that viruses are becoming resistant to drugs known as M2 blockers or adamantines. Those drugs, which impede the flu virus from copying itself, have been used to treat and prevent infections, mainly in the elderly, for nearly 4 decades.

"We can see resistance increasing to this class of drugs," says virologist Rick A. Bright of the Centers for Disease Control and Prevention (CDC) in Atlanta. "Fortunately, we have other drugs, like Tamiflu."

But Tamiflu, the trade name for oseltamivir, and its chemical relative zanamivir (Relenza) are patented, more expensive than M2 blockers, and manufactu

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content